Queensland Bladder Cancer Initiative 

QBCI are working hard to improve outcomes for patients diagnosed with bladder cancer.

Bladder cancer is common, deadly and the most expensive cancer to treat. It is the ninth most common cancer worldwide, and affects both men and women (with a 3:1 ratio).

QBCI have been working tirelessly since 2018 to improve outcomes for patients diagnosed with bladder cancer. The initiative aims to tackle bladder cancer head on by improving diagnostic measures through the development of a non-invasive "liquid" urinary biomarker to address the challenge of screening in addition to long-term surveillance of treated patients who are at high risk for developing recurrent bladder cancer. QBCI are also aiming to improve patient experience and outcomes via the formation of a consumer bureau to contribute to a collaborative and relevant BICa program.

The team are also establishing a bladder cancer registry for identification of practice patterns for BICa in Queensland, thus enabling the identification of disparities in availability and treatment practices in different settings (metropolitan, regional, or remote; public versus private systems) with the goal of improving outcomes via increased equity of care.

QBCI is a research project funded by the PA Research Foundation. The Lucky Duck Lottery helps to raise funds to support this research and help patients affected by Bladder Cancer. To support this research, purchase a Lucky Duck Lottery Ticket. 

Buy Tickets 

Copyright © 2019 Lucky Duck Lottery. Powered by Synergy 8